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The paper presents a comprehensive and well-designed systematic review and meta-analysis for estimating prevalence rates for type 2 diabetes in women of childbearing age in Africa between 2000 and 2016. Originality This is potentially an important study assessing the prevalence of type 2 diabetes in African women. The research question is welldefined and based on protocol published previously. Comments 1. Eligibility criteria: the authors need to justify the selection of this study period. Why only included studies from 2000 onwards? 2. In the data synthesis and analysis section, the authors list the age groups found in the included studies. These are results and would be better placed in the Results section. 3. It is not mentioned in the Methods on the plan to only include studies reporting age-and gender-specific rates in the metaanalysis. This is mentioned in the Search Results section, but need to be mentioned earlier for clarity. 4. Table 1 is mispecified on page 10, Line 8. i.e. it is not matchgin the Table 1 presented on pages 11, 12. 5. On page 11 line 4, the authors state "A total of 39 studies, from 27 countries, with 52 075 women of child bearing age….." but also state "A total of 81 studies from 39 countries were included, totaling 52 075 participants" in the Abstract. Please revise these inconsistent statements. 6. Please describe briefly of how the ROB score in Appendix 2 was computed. 7. In Discussion (Line 18-32) the authors elaborate on possible utility of FPG testing, but it would be useful to discuss the potential role of HbA1c testing.
8. There are few typos e.g. "80 included studies..." Page 10, line 8; page 15 Line 23; page 19 Line13. Please revise. 9. The URL provided in reference #5 is outdated. Please update.
REVIEWER
Dr S Bellary Aston University,UK REVIEW RETURNED 22-Oct-2018
GENERAL COMMENTS
Thank you for asking me to review this manuscript. Maternal diabetes has a great impact on maternal health as well as risk of diabetes in the offspring and therefore huge implications for population health. Given the projected increase in diabetes in the african continent this work is highly relevant especially considering the scarcity of data from this part of the world.
The objectives are well defined and the outcomes are well stated. It would have been good if the GDM studies were included as well given that the T2DM,IFG and IGT may not fully capture the extent of risk of maternal diabetes.
The methodology is sound and thorough. However, there are a couple of points. Firstly, the sample size of some studies ( using a cut off of 100 subjects) is highly variable and i wonder if a higher cut off e.g. 1000 patients would have been more appropriate considering these are prevalence studies and a small sample size can have an overall effect especially when assessing pooled prevalence. Secondly, although the intention to include all african studies is understandable, there is a huge variation in the geographical prevalences e.g. very high in south africa. Clearly, prevalence varies with regards to economic status of these countries and again it is likely that the heterogeneity may be due to the huge economic variation between the countries. How representative would the results be under these circumstances . Could a analysis be undertaken based on the economic status of the different countries ?
It is interesting that the prevalence of T2DM, IGT and IFG are almost similar. Ideally you would expect a higher prevalence of pre diabetes states . Are there any reasons for this deviation from an expected pattern?
In general results are well presented and clear. The discussion is also well written but it would be good of some of the points raised above are adequately addressed.
REVIEWER

Alipasha Meysamie Tehran University of Medical Sciences IR Iran REVIEW RETURNED
12-Nov-2018
GENERAL COMMENTS
The abstract is too concise need more explanation specifically in results and method parts.
In the results the number of included studies mentioned 80, however in the abstract and method it is reported as 81. The methodology is sound and thorough. However, there are a couple of points. Firstly, the sample size of some studies ( using a cut off of 100 subjects) is highly variable and i wonder if a higher cut off e.g. 1000 patients would have been more appropriate considering these are prevalence studies and a small sample size can have an overall effect especially when assessing pooled prevalence.
We also agree with this comment. Forest plots of T2DM according to the age groups and urban and rural reports shall be included.
The forest plots are included as supplementary files
